1-1 of 1
Tim Bugdahn
Close
Sort by
Journal Articles

The JAK1/2 Inhibitor Ruxolitinib Kills Malignant Plasma Cells and Is Synergistic with PI3K and mToR Inhibitors

Renate Burger, Tim Bugdahn, Matthias Staudinger, Anna Lena Michaelis, Matthias Peipp, Andreas Guenther, Martin Gramatzki
Journal: Blood
Blood (2012) 120 (21): 1844.
https://doi.org/10.1182/blood.V120.21.1844.1844
Published: 2012